List view / Grid view
New data from a completed Phase 3 trial show Lilly’s Trulicity (dulaglutide) 1.5 mg plus a sulfonylurea was significantly more effective than a sulfonylurea alone in lowering haemoglobin A1c (A1C) from baseline after 24 weeks of treatment.
2 December 2015 | By Victoria White
Novo Nordisk has released new data that shows Victoza (liraglutide) provides a greater HbA1c reduction and an improved likelihood of reaching glycaemic goals compared to sodium-glucose cotransporter 2 inhibitors...
1 December 2015 | By CI Precision
CI Precision and our channel partner PT Electronics are exhibiting at CPhi P-MEC India 2015 in Mumbai on 1-3 December...
1 December 2015 | By Tecan
The Madrid Technology Center of global energy company Repsol relies on two Freedom EVO® platforms for colony picking and enzymatic assays for research into fossil fuel alternatives, using Tecan’s 350 µl nested LiHa disposable tips to achieve extended walkaway times...
1 December 2015 | By Dolomite
Dolomite, part of the Blacktrace group of companies, is celebrating a decade of excellence in the design and manufacture of novel, high quality microfluidic products, including individual components such as pumps, chips, connectors, temperature controllers and sensors, software solutions and complete microfluidic systems...
1 December 2015 | By Black Swan Analysis
Research and Markets has announced the addition of the "Epiomic Epidemiology Series: Atopic Dermatitis Forecast in 17 Major Markets 2015-2025" report to their offering...
1 December 2015 | By Victoria White
GlobalData says the rising number of opioid-induced constipation sufferers is largely down to overall population increase...
1 December 2015 | By Victoria White
The novel, oral small molecule inhibitor of VAP-1 is a cell-adhesion molecule that may be effective in the treatment of inflammatory diseases...
1 December 2015 | By Victoria White
The assay has been selected by the International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG) to be part of a trial studying the effects of palbociclib in breast cancer...
1 December 2015 | By Victoria White
These first vaccine doses will be available to implement one dose of IPV for all infants in the country...
1 December 2015 | By Victoria White
An official decision on the Ophran Drug Designation is expected from the European Commission in December...
1 December 2015 | By Victoria White
Empliciti (elotuzumab) has been approved as combination therapy with Revlimid (lenalidomide) and dexamethasone (ERd) in patients who have received one to three prior therapies.
30 November 2015 | By Victoria White
Stelara (ustekinumab), approved for the treatment of plaque psoriasis and active psoriatic arthritis in many countries, is a human monoclonal antibody that targets interleukin (IL)-12 and IL-23 cytokines...
30 November 2015 | By
The European Medicines Agency (EMA) has accepted for review, the marketing authorisation application (MAA) for Helsinn Group’s anamorelin HCI...
27 November 2015 | By Victoria White
Sirukumab is an investigational human anti-IL-6 monoclonal antibody that selectively binds with high affinity to the IL-6 cytokine...
